Noninfective disorders of pinna

H8_PINNADIS

auditory system disease: Pathological processes of the ear, the hearing, and the equilibrium system of the body.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H61.1 Hospital discharge: ICD-9 — 3803 Cause of death: ICD-10 — H61.1 Cause of death: ICD-9 — 3803 2 out of 7 registries used, show all original rules.	80
4. Check minimum number of events None	80
5. Include endpoints None	80
6. Filter based on genotype QC (FinnGen only)	80

Control definitions (FinnGen only)

Control exclude: H8_EXTERNAL

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H61
Name in latin: Morbositates non infectiosae auriculae

NAME	H8_PINNADIS
CONTROL_EXCLUDE	H8_EXTERNAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H611
HD_ICD_9	3803
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H611
COD_ICD_9	3803
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Noninfective disorders of pinna based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	684	319	359
Only index persons	610	287	323
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	32.55	34.65	30.36
Only index persons	32.98	37.05	29.37

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	80	45	35
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	50.23	46.07	55.57

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
70: Matched controls
698

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H61.1

ICD-10 Finland

Noninfective disorders of pinna

+∞

80.5

H60.9

ICD-10 Finland

Otitis externa, unspecified

14.2

7.4

3803B

ICD-9 Finland

Disorders of external ear, Non-infectious disorders of pinna[DEFORMATIO AURICULARIS AQCUISITA]

+∞

6.3

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

3.96

6.12

1.7

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

3.20

4.19

1.2

1.4

173.3

461.2

titre

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.98

3.28

1.9

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.90

2.99

1.9

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

5.31

2.45

1.2

1.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

142

2.11

2.27

2.5

1.3

2.0

2.3

g/l

0.74

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.29

2.22

2.0

1.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

155

2.00

2.06

1.3

1.2

8.4

0.9

u/ml

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.94

2.00

2.1

1.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

4.37

1.85

1.0

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

3.33

1.69

1.2

5.6

5.9

u/l

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2.97

1.69

1.0

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

314

1.71

1.54

5.2

5.5

1.8

e9/l

0.09

284

(42870588) Differential panel, method unspecified - Blood

189

1.74

1.46

5.4

5.1

—

(3001604) Monocytes [#/volume] in Blood

299

1.68

1.44

5.3

5.6

0.5

0.6

e9/l

0.11

264

(3006315) Basophils [#/volume] in Blood

299

1.68

1.44

5.3

5.7

0.0

e9/l

0.22

267

(3013115) Eosinophils [#/volume] in Blood

310

1.66

1.40

5.2

5.9

0.2

e9/l

0.13

280

(3013650) Neutrophils [#/volume] in Blood by Automated count

349

1.66

1.39

6.7

10.3

4.5

3.9

e9/l

0.69

316

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

496

1.72

1.30

3.8

4.0

14.5

14.9

pmol/l

0.58

456

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

152

1.72

1.28

1.7

3.7

633.9

966.6

ng/l

0.68

129

(3004588) Protein electrophoresis panel - Serum or Plasma

2.41

1.21

3.3

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

453

1.59

1.10

3.1

—

(3021589) Normoblasts [#/volume] in Blood

295

1.55

1.09

9.3

8.4

0.0

e9/l

0.50

244

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.98

0.96

1.3

1.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.23

0.94

4.7

6.4

23.8

24.0

mmol/l

—

(3013707) Erythrocyte sedimentation rate by Westergren method

464

1.50

0.90

3.9

4.0

15.6

11.1

mm/h

0.83

439

(40768443) Skin Pathology biopsy report

2.08

0.89

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

595

1.62

0.85

15.6

13.4

40.6

40.5

0.06

475

(40768793) Breast Pathology biopsy report

0.00

0.80

0.0

1.3

—

(3032080) INR in Blood by Coagulation assay

226

1.44

0.77

12.5

6.7

1.2

inr

—

(3023368) Bacteria identified in Blood by Culture

154

1.49

0.75

5.2

3.8

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1.98

0.72

3.0

1.8

24.8

41.1

nmol/l

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.77

0.65

6.2

10.9

93.3

94.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

182

0.66

0.63

2.2

2.9

—

(3002256) Pathology report gross observation

1.61

0.63

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.60

0.62

1.4

2.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.60

0.62

2.1

2.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

0.00

0.61

0.0

2.4

—

3.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

235

1.37

0.60

4.4

2.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.53

0.59

3.1

3.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.59

0.0

4.7

—

34.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

665

1.60

0.58

15.2

12.7

28.3

20.2

mg/l

0.80

521

(3044889) 12 lead EKG panel

423

1.34

0.57

3.8

3.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.52

0.55

1.8

1.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.51

0.55

1.9

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.58

0.54

1.0

1.3

—

(4010399)

1.58

0.54

1.0

1.6

—

(40768804) Tissue Pathology biopsy report

239

1.33

0.53

2.4

2.1

—

(3026008) Bacteria identified in Urine by Culture

187

0.70

0.53

2.7

—

(3000494) Fungus identified in Specimen by Culture

1.56

0.52

1.6

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

239

0.73

0.51

3.6

3.7

24.5

32.6

ng/l

0.30

158

(3018095) Leukocytes [#/volume] in Urine

250

1.32

0.51

3.2

3.1

16.6

53.8

e6/l

1.05

179

(3011397) Hemoglobin [Presence] in Urine by Test strip

148

1.37

0.49

2.3

3.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

247

0.75

0.47

2.6

3.4

—

(40761536) Microorganisms panel - Urine sediment

1.45

0.44

2.5

2.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

0.00

0.41

0.0

2.3

—

0.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.41

0.0

3.5

—

55.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.2

—

62.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

240

1.26

0.37

2.5

1.8

100.9

98.3

pmol/l

0.11

124

(3031040) Bacteria [#/volume] in Urine by Automated count

439

1.23

0.35

4.2

4.0

—

62.8

—

(3000991) Gas panel - Venous blood

1.36

0.34

4.3

7.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.36

0.34

1.3

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.33

0.34

1.8

—

(3025941) Bacteria identified in Stool by Culture

1.33

0.34

1.0

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

130

1.29

0.32

1.9

1.7

1.3

mg/l

—

108

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

613

0.80

0.31

4.4

3.6

1.3

mmol/l

0.15

568

(40758558) Short blood count panel - Blood

169

1.24

0.29

6.8

6.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

275

1.21

0.29

8.9

6.1

1.2

mmol/l

0.10

235

(3022145) Colonoscopy Study observation

1.30

0.27

1.0

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

133

1.25

0.27

2.5

2.2

—

(40768797) Stomach Pathology biopsy report

1.21

0.26

1.3

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

115

1.26

0.25

1.7

926.3

1233.8

nmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.69

0.25

1.2

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

178

0.81

0.25

8.0

3.4

5.1

10.6

mg/mmol

—

100

(40761535) Cells panel - Urine sediment

1.37

0.24

6.0

3.8

—

(3042936) Bacteria identified in Isolate by Culture

1.30

0.23

2.0

1.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

613

1.22

0.23

15.7

11.9

84.2

85.2

ml/min/173m2

0.11

494

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.27

0.22

2.5

1.9

—

(3002582) Erythrocytes [#/volume] in Urine

213

1.18

0.22

3.3

2.6

17.5

30.8

e6/l

0.49

165

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.5

—

3.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

0.21

0.0

2.2

—

97.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.21

0.0

2.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(1761868) Lipid panel - Serum or Plasma

237

0.85

0.21

3.0

2.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.21

0.0

5.3

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.21

0.0

3.1

—

1.6

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.21

0.0

3.1

—

7.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.21

0.0

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

5.2

—

137.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.30

0.21

2.0

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

156

1.20

0.21

2.1

2.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.21

0.0

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.20

0.0

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.20

0.0

1.1

—

(36304419) Bacteria [Presence] in Urine

195

1.18

0.20

3.0

2.3

—

(3000492) Spirometry study

1.25

0.19

1.1

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.20

0.18

4.9

9.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

139

1.19

0.18

3.8

4.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

120

1.20

0.18

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

618

1.18

0.17

4.8

4.2

6.0

5.8

mmol/l

0.37

576

(3003694) ABO and Rh group [Type] in Blood

189

0.87

0.13

1.4

1.5

—

(3013512) EKG study

153

1.14

0.12

3.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

301

1.11

0.12

3.5

3.9

—

(40761511) CBC panel - Blood by Automated count

685

1.18

0.11

13.8

11.8

—

(3044640) Blood type and Crossmatch panel - Blood

193

1.12

0.11

2.6

2.2

—

(3030467) Casts [#/volume] in Urine by Automated count

194

1.11

0.10

3.1

2.4

0.6

0.3

e6/l

0.26

147

(3003396) Base excess in Arterial blood by calculation

1.06

0.09

5.3

6.6

0.2

0.4

mmol/l

—

(4035726)

1.04

0.08

1.5

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.03

0.08

2.4

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

100

1.12

0.05

2.6

2.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

450

1.05

0.03

4.7

4.2

—

(3035350) Ketones [Presence] in Urine by Test strip

321

1.05

0.03

2.4

3.3

0.0

estimate

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

142

1.07

0.02

1.4

1.6

455.1

437.7

pmol/l

—

124

(3021601) Nitrite [Presence] in Urine by Test strip

323

1.04

0.01

2.9

4.4

0.0

estimate

—

(3019150) Specific gravity of Urine by Refractometry

134

1.05

0.00

2.4

3.5

—

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

636

0.96

0.00

4.8

4.1

4.5

4.7

mmol/l

0.87

592

(3009261) Glucose [Presence] in Urine by Test strip

327

1.02

0.00

2.4

3.3

0.0

estimate

—

(3029937) Albumin [Presence] in Urine by Test strip

175

0.96

0.00

3.1

3.6

0.0

estimate

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

136

1.04

0.00

1.4

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

125

1.05

0.00

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

646

1.03

0.00

4.9

4.5

2.6

2.8

mmol/l

0.70

602

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

634

0.97

0.00

4.7

4.0

1.4

1.5

mmol/l

0.64

589

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

3.3

—

106.6

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.00

0.0

2.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

239.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.0

1.4

—

(4027681)

0.00

0.0

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.0

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

0.00

0.0

1.2

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3044941) Cell count panel - Synovial fluid

0.00

0.0

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.0

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

0.0

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.0

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

0.0

2.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(3011648) Oxygen content in Venous blood

0.00

0.0

2.1

—

10.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.0

3.8

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.4

—

(3017569) Oxygen content in Arterial blood

0.00

0.0

2.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

2.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

3.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.0

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.0

1.3

—

75.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

3.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.0

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

2.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.0

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.0

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.0

1.6

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

3.3

—

4.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(3045716) Anion gap in Serum or Plasma

0.00

0.0

2.2

—

6.6

—

(3051651) Icteric interference index of Serum or Plasma

0.00

0.0

3.4

—

(3012544) pH of Venous blood

1.00

0.00

2.8

2.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.0

1.3

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.0

2.0

—

67.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.01

0.00

1.7

1.8

—

(36660697) Celiac disease serology panel - Serum

1.02

0.00

1.2

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_PINNADIS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have H8_PINNADIS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: H8_PINNADIS – Noninfective disorders of pinna

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Noninfective disorders of pinna

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints